Universitätsklinikum Heidelberg

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article Positionspapier: Telemedizin in der Berufsdermatologie - Aktueller Stand und Perspektiven (2018) Elsner P, Bauer A, Diepgen TL, Drexler H, Fartasch M, John SM, Schliemann S, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Erratum to: Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article, Erratum Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article Whither systems medicine? (2018) Apweiler R, Beissbarth T, Berthold MR, Bluethgen N, Burmeister Y, Dammann O, Deutsch A, et al. Journal article Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence (2018) Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, Pfohler C, et al. Journal article Hyponatremia and Nephritis - Rare Side Effects of Checkpoint Inhibitors in Patients with metastatic Melanoma (2018) Mitzel-Rink H, Hassel J, Berking C, Gutzmer R, Heinzerling L, Majenka P, Meier F, et al. Conference contribution Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients (2018) Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, et al. Journal article